Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/42880| Title: | Semaglutide and Cardiovascular Outcomes | Authors: | Belkhouribchia, Jamal | Issue Date: | 2024 | Publisher: | MASSACHUSETTS MEDICAL SOC | Source: | NEW ENGLAND JOURNAL OF MEDICINE, 390 (8) , p. 767 | Notes: | Belkhouribchia, J (corresponding author), Endocrinol Ctr, Hasselt, Belgium. | Keywords: | Humans;Obesity;Glucagon-Like Peptides;Diabetes Mellitus, Type 2 | Document URI: | http://hdl.handle.net/1942/42880 | ISSN: | 0028-4793 | e-ISSN: | 1533-4406 | DOI: | 10.1056/NEJMc2400414 | ISI #: | 001185614100002 | Category: | A1 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.